Anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| FC |
---|---|
Primary Accession | Q13984 |
Reactivity | Human |
Host | Recombinant |
Clonality | Monoclonal |
Isotype | Human IgG1, kappa |
Alias Symbol | CEA |
---|---|
Other Names | CEA |
Appearance | Colorless liquid |
Formulation | 200 µg affinity purified human antibody in phosphate-buffered saline (PBS) containing 0.02% Proclin 300 |
Reconstitution & Storage | -20 °C |
Background Descriptions | |
Precautions | Anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion normally produced in gastrointestinal tissue during fetal development, but only at very low levels in adults.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.